AMAG AI traffic safety technology

New hope in global fight against antibiotic resistant superbugs

A technology that could reverse antibiotic resistance will advance towards the…


World-first skin cancer treatment aims to help transplant patients

A new medication which can be applied to the skin could help prevent organ…


TTRA for diabetes and cardiovascular disease announces research plans and partners

MTPConnect’s Targeted Translation Research Accelerator (TTRA) initiative for…


UQ congratulates Vaxxas on $30m partnership

A startup company developing technology based on University of Queensland…


Landmark deal for UQ-Trinity inflammation startup

A startup company developing treatments for inflammatory diseases based on…


UniQuest's drug discovery project awarded key funding to progress prostate cancer treatment

  UniQuest’s drug discovery team is one of just eight projects to be…


UniQuest and CSL Limited partner to develop potential treatment for Sjogren’s Syndrome

UniQuest, The University of Queensland’s (UQ’s) technology transfer company has…


Licence agreement creates golden opportunity for cancer diagnostic technology

A novel rapid cancer diagnostic technology with the potential to quickly and…


UQ's Vaxxas Nanopatch is a novel vaccine delivery technology to target vaccines to the cells immediately below the surface of the skin.

UQ congratulates vaccine delivery spinout on global deals

A spinout company developing technology based on innovative University of…